AAAAAA

   
Results: 1-16 |
Results: 16

Authors: Peracchi, M Porretti, S Gebbia, C Pagliari, C Bucciarelli, P Epaminonda, P Manenti, S Arosio, M
Citation: M. Peracchi et al., Increased glucose-dependent insulinotropic polypeptide (GIP) secretion in acromegaly, EUR J ENDOC, 145(1), 2001, pp. R1-R4

Authors: Biguzzi, E Merati, G Liaw, PCY Bucciarelli, P Oganesyan, N Qu, DF Gu, JM Fetiveau, R Esmon, CT Mannucci, PM Faioni, EM
Citation: E. Biguzzi et al., A 23bp insertion in the endothelial protein C receptor (EPCR) gene impairsEPCR function, THROMB HAEM, 86(4), 2001, pp. 945-948

Authors: Martinelli, I Legnani, C Bucciarelli, P Grandone, E De Stefano, V Mannucci, PM
Citation: I. Martinelli et al., Risk of pregnancy-related venous thrombosis in carriers of severe inherited thrombophilia, THROMB HAEM, 86(3), 2001, pp. 800-803

Authors: Menegatti, M Asselta, R Duga, S Malcovati, M Bucciarelli, P Mannucci, PM Tenchini, ML
Citation: M. Menegatti et al., Identification of four novel polymorphisms in the A alpha and gamma fibrinogen genes and analysis of association with plasma levels of the protein, THROMB RES, 103(4), 2001, pp. 299-307

Authors: Cattaneo, M Lombardi, R Lecchi, A Bucciarelli, P Mannucci, PM
Citation: M. Cattaneo et al., Low plasma levels of vitamin B-6 are independently associated with a heightened risk of deep-vein thrombosis, CIRCULATION, 104(20), 2001, pp. 2442-2446

Authors: Sartorio, A Cattaneo, M Bucciarelli, P Bottasso, B Porretti, S Epaminonda, P Faglia, G Arosio, M
Citation: A. Sartorio et al., Alterations of haemostatic and fibrinolytic markers in adult patients withgrowth hormone deficiency and with acromegaly, EXP CL E D, 108(7), 2000, pp. 486-492

Authors: Federici, AB Rand, JH Bucciarelli, P Budde, U van Genderen, PJJ Mohri, H Meyer, D Rodeghiero, F Sadler, JE
Citation: Ab. Federici et al., Acquired von Willebrand syndrome: Data from an International Registry, THROMB HAEM, 84(2), 2000, pp. 345-349

Authors: Martinelli, I Bucciarelli, P Margaglione, M De Stefano, V Castaman, G Mannucci, PM
Citation: I. Martinelli et al., The risk of venous thromboembolism in family members with mutations in thegenes of factor V or prothrombin or both, BR J HAEM, 111(4), 2000, pp. 1223-1229

Authors: Peyvandi, F Mannucci, PM Bucciarelli, P Zeinali, S Akhavan, S Sacchi, E Merlini, PA Perry, DJ
Citation: F. Peyvandi et al., A novel polymorphism in intron 1a of the human factor VII gene (G73A): study of a healthy Italian population and of 190 young survivors of myocardialinfarction, BR J HAEM, 108(2), 2000, pp. 247-253

Authors: Bucciarelli, P Rosendaal, FR Tripodi, A Mannucci, PM De Stefano, V Palareti, G Finazzi, G Baudo, F Quintavalla, R
Citation: P. Bucciarelli et al., Risk of venous thromboembolism and clinical manifestations in carriers of antithrombin, protein C, protein S deficiency, or activated protein C resistance - A multicenter collaborative family study, ART THROM V, 19(4), 1999, pp. 1026-1033

Authors: Martinelli, I Taioli, E Bucciarelli, P Akhavan, S Mannucci, PM
Citation: I. Martinelli et al., Interaction between the G20210A mutation of the prothrombin gene and oral contraceptive use in deep vein thrombosis, ART THROM V, 19(3), 1999, pp. 700-703

Authors: Cattaneo, M Federici, AB Lecchi, A Agati, B Lombardi, R Stabile, F Bucciarelli, P
Citation: M. Cattaneo et al., Evaluation of the PFA-100 (R) system in the diagnosis and therapeutic monitoring of patients with von Willebrand disease, THROMB HAEM, 82(1), 1999, pp. 35-39

Authors: Bolliger-Stucki, B Bucciarelli, P Lammle, B Furlan, M
Citation: B. Bolliger-stucki et al., Fibrinogen Milano XIII (A alpha Arg -> Gly): A dysfunctional variant with an amino acid substitution in the N-terminal polymerization site, THROMB RES, 96(5), 1999, pp. 399-405

Authors: Bucciarelli, P Alatri, A Moia, M
Citation: P. Bucciarelli et al., Anticoagulation for venous thromboembolism, N ENG J MED, 341(7), 1999, pp. 539-539

Authors: Faioni, EM Franchi, F Bucciarelli, P Margaglione, M De Stefano, V Castaman, G Finazzi, G Mannucci, PM
Citation: Em. Faioni et al., Coinheritance of the HR2 haplotype in the factor V gene confers an increased risk of venous thromboembolism to carriers of factor V R506Q (Factor V leiden), BLOOD, 94(9), 1999, pp. 3062-3066

Authors: Alatri, A Bucciarelli, P Moia, M
Citation: A. Alatri et al., Subcutaneous heparin for deep venous thrombosis, ANN INT MED, 130(12), 1999, pp. 1027-1027
Risultati: 1-16 |